HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lei Fan Selected Research

MicroRNAs (MicroRNA)

1/2024Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway.
1/2023Circular RNAs are associated with the resistance to Newcastle disease virus infection in duck cells.
1/2023RNA sequencing reveals CircRNA expression profiles in chicken embryo fibroblasts infected with velogenic Newcastle disease virus.
1/2021Integrated analysis of multiple microarray studies to identify novel gene signatures in preeclampsia.
4/2020EBV-miR-BHRF1-1 Targets p53 Gene: Potential Role in Epstein-Barr Virus Associated Chronic Lymphocytic Leukemia.
1/2020MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability.
10/2018NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
11/2017Peripheral Blood miR-181-5p Serves as a Marker for Screening Patients with Osteoarthritis by Targeting TNFα.
12/2012Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.
7/2012miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lei Fan Research Topics

Disease

84Neoplasms (Cancer)
05/2024 - 12/2009
49B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2023 - 08/2009
30Breast Neoplasms (Breast Cancer)
04/2024 - 07/2009
21Inflammation (Inflammations)
02/2024 - 07/2007
20Lymphoma (Lymphomas)
01/2024 - 06/2012
20Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2022 - 02/2009
18Carcinogenesis
01/2022 - 08/2007
16Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 12/2009
15Infections
12/2023 - 05/2013
12Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 07/2008
10Wounds and Injuries (Trauma)
11/2023 - 10/2014
10Neoplasm Metastasis (Metastasis)
11/2023 - 06/2011
9Disease Progression
08/2023 - 10/2008
8Triple Negative Breast Neoplasms
01/2024 - 01/2020
8Coronary Artery Disease (Coronary Atherosclerosis)
07/2023 - 12/2019
8Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 02/2011
7Spinal Cord Injuries (Spinal Cord Injury)
01/2024 - 05/2018
7Insulin Resistance
01/2023 - 12/2017
7Hodgkin Disease (Hodgkin's Disease)
01/2023 - 01/2016
6Leukemia
05/2024 - 06/2010
6Osteosarcoma (Osteogenic Sarcoma)
01/2024 - 06/2011
6Lung Neoplasms (Lung Cancer)
09/2023 - 09/2015
6Colitis
12/2018 - 12/2009
6B-Cell Lymphoma (Lymphoma, B Cell)
01/2017 - 05/2013
5Neutropenia
01/2024 - 12/2020
5Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2024 - 01/2020
5Alzheimer Disease (Alzheimer's Disease)
11/2023 - 01/2018
5Adenocarcinoma of Lung
09/2023 - 01/2017
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2023 - 05/2008
5Colitis-Associated Neoplasms
06/2017 - 12/2009
5Burns
05/2015 - 12/2011
4Hepatocellular Carcinoma (Hepatoma)
05/2024 - 01/2020
4Hyperthermia
04/2023 - 12/2018
4Anemia
03/2021 - 06/2015
4Pre-Eclampsia (Preeclampsia)
01/2021 - 12/2019
4Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 12/2008

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
05/2024 - 02/2009
21Messenger RNA (mRNA)IBA
07/2023 - 02/2011
16HydrogelsIBA
01/2024 - 05/2018
15Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 08/2014
15MicroRNAs (MicroRNA)IBA
01/2024 - 06/2010
14Biomarkers (Surrogate Marker)IBA
05/2024 - 04/2012
12RNA (Ribonucleic Acid)IBA
05/2024 - 06/2010
11CarbonIBA
07/2023 - 02/2018
11CytokinesIBA
01/2023 - 05/2008
11Rituximab (Mabthera)FDA Link
01/2023 - 08/2009
10Therapeutic UsesIBA
01/2024 - 05/2015
10Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
03/2023 - 07/2009
8EnzymesIBA
01/2024 - 01/2012
8Indicators and Reagents (Reagents)IBA
12/2023 - 12/2010
8DNA (Deoxyribonucleic Acid)IBA
12/2023 - 01/2016
8fludarabineIBA
01/2023 - 07/2008
8L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2016 - 09/2009
7Glucose (Dextrose)FDA LinkGeneric
01/2023 - 12/2017
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 07/2008
7Circular RNAIBA
01/2023 - 01/2019
7Triglycerides (Triacylglycerol)IBA
12/2022 - 12/2019
7Immunoglobulins (Immunoglobulin)IBA
10/2021 - 10/2008
5IonsIBA
02/2024 - 04/2022
5polydopamineIBA
12/2023 - 10/2020
5Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 07/2014
5CollagenIBA
11/2023 - 10/2014
5Oxidoreductases (Dehydrogenase)IBA
04/2023 - 07/2009
5Peptides (Polypeptides)IBA
06/2022 - 10/2014
5Vitamin DFDA LinkGeneric
02/2021 - 04/2020
4Proteasome Endopeptidase Complex (Proteasome)IBA
04/2024 - 07/2021
4Phenobarbital (Luminal)FDA Link
01/2024 - 01/2012
4InterferonsIBA
12/2023 - 01/2015
4Caspase 3 (Caspase-3)IBA
12/2023 - 11/2010
4Anti-Bacterial Agents (Antibiotics)IBA
10/2023 - 12/2010
4Hemoglobins (Hemoglobin)IBA
07/2023 - 06/2013
4Toll-Like Receptor 3IBA
04/2023 - 10/2011
4Transcription Factors (Transcription Factor)IBA
01/2023 - 04/2016
4Fibrinogen (Factor I)FDA Link
01/2023 - 06/2015
4CholesterolIBA
12/2022 - 10/2018
4Paclitaxel (Taxol)FDA LinkGeneric
07/2022 - 01/2020
4human ERBB2 proteinIBA
06/2021 - 01/2019
4C-Reactive ProteinIBA
05/2021 - 06/2015
4AlbuminsIBA
04/2021 - 04/2019
4HDL CholesterolIBA
03/2021 - 12/2019
4MagnesiumIBA
01/2021 - 12/2017
4salicylhydroxamic acid (SHAM)IBA
12/2020 - 12/2011
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2019 - 04/2014
4Paris saponin VIIIBA
07/2019 - 03/2014
4Polysaccharides (Glycans)IBA
12/2018 - 10/2013
4Dextrans (Dextran)FDA Link
10/2017 - 03/2014
3AntioxidantsIBA
02/2024 - 10/2020
3Alanine Transaminase (SGPT)IBA
01/2024 - 01/2014
3PlatinumIBA
12/2023 - 01/2020
3Fatty Acids (Saturated Fatty Acids)IBA
12/2023 - 10/2023

Therapy/Procedure

67Therapeutics
01/2024 - 08/2009
22Drug Therapy (Chemotherapy)
12/2023 - 12/2008
8Photothermal Therapy
03/2023 - 02/2018
7Percutaneous Coronary Intervention
07/2023 - 12/2019
6Neoadjuvant Therapy
08/2023 - 05/2016
5Immunotherapy
05/2024 - 06/2015
4Injections
03/2023 - 01/2022
4Adjuvant Chemotherapy
06/2021 - 01/2012
4Transplantation
04/2019 - 12/2008
3Debridement
10/2023 - 01/2019